Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New 5-Session breast radiation shows promise in early cancer trial

NCT ID NCT03581136

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times

Summary

This study tests a highly targeted radiation technique called stereotactic partial breast irradiation (S-PBI) for women with early-stage breast cancer. The treatment uses a special device (GammaPod) to deliver radiation in just 5 sessions, aiming to kill cancer cells while sparing healthy tissue. Researchers are checking how the breast looks and feels after 3 years, and whether the cancer comes back. The study involves 74 women and is currently active but not recruiting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UT Southwestern Medical Centre

    Dallas, Texas, 75390, United States

  • University of Maryland Medical Center

    Baltimore, Maryland, 21201, United States

Conditions

Explore the condition pages connected to this study.